Observers were encouraged to take breaks between trials, each session was divided into two blocks, with a break of at least 2 mins between blocks, and unlimited rest allowed between sessions.
The duration of each session was between 30 150 minutes, with an average of one hour.
The number of participants in each focus group ranged from four to eight individuals, and each session was between 1.5 and 2 hours in duration.
Introspection data for each session was normalized between 0 and 1 across session and participants.
The dose of miriplatin used in each session was also compared between the 2 groups.
To assess drug effects on arousal and activity, the numbers of hurdle crossings during the habituation period preceding each training session as well as the intertrial activity, that is, the numbers of hurdle crossings occurring between the trials of each training session, were monitored.
Those in the NET condition received 4 therapy sessions of 60 90 minutes each, which lasted 2 weeks with 2,3, or 4 days between each session, and were assessed post treatment (T2), after another 2 weeks (T3) and then after 2 months (T4) by using same scales.
The effect of one-, two- or three-year gaps between training sessions was also investigated.
